Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?

EBioMedicine

Volumn 5, Issue , 2016, Pages 211-216

  Jamuar, Saumya Shekhar ^a,b   Kuan, Jyn Ling ^c,g   Brett, Maggie ^a   Tiang, Zenia ^c,g   Tan, Wilson Lek Wen ^c,g   Lim, Jiin Ying ^a   Liew, Wendy Kein Meng ^a,b   Javed, Asif ^c   Liew, Woei Kang ^a   Law, Hai Yang ^a,b   Tan, Ee Shien ^a,b   Lai, Angeline ^a,b   Ng, Ivy ^a,b   Teo, Yik Ying ^d   Venkatesh, Byrappa ^e   Reversade, Bruno ^f   Tan, Ene Choo ^a   Foo, Roger ^c,g  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b Singapore Health Services   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^f INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^g NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Genomic sequencing; Incidental findings; Personalized medicine

Indexed keywords

ALGORITHM; ARTICLE; BIOINFORMATICS; BREAST CANCER; FRAMESHIFT MUTATION; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE MUTATION; HEALTH CARE PLANNING; OVARY CARCINOMA; PATHOGENICITY; PERSONALIZED MEDICINE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; CHROMOSOMAL MAPPING; EXOME; GENETIC DATABASE; GENETIC VARIATION; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; INCIDENTAL FINDING; MOLECULAR GENETICS; MUTATION; SINGAPORE;

CHROMOSOME MAPPING; DATABASES, GENETIC; EXOME; GENETIC VARIATION; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INCIDENTAL FINDINGS; MOLECULAR SEQUENCE ANNOTATION; MUTATION; PRECISION MEDICINE; SINGAPORE;

EID: 84957630061     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.01.030     Document Type: Article

References (43)

1. Adzhubei I., Jordan D.M., Sunyaev S.R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013, (Chapter 7: Unit7 20).
2. Amendola L.M., Dorschner M.O., Robertson P.D., Salama J.S., Hart R., Shirts B.H., et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015, 25(3):305-315.
3. Ayuso C., Millan J.M., Dal-Re R. Management and return of incidental genomic findings in clinical trials. Pharmacogenomics J. 2015, 15(1):1-5.
4. Ballinger M.L., Mitchell G., Thomas D.M. Surveillance recommendations for patients with germline TP53 mutations. Curr. Opin. Oncol. 2015, 27(4):332-337.
5. Berg J.S., Khoury M.J., Evans J.P. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet. Med. 2011, 13(6):499-504.
6. Burke W., Antommaria A.H., Bennett R., Botkin J., Clayton E.W., Henderson G.E., et al. Recommendations for returning genomic incidental findings? We need to talk!. Genet. Med. 2013, 15(11):854-859.
7. DePristo M.A., Banks E., Poplin R., Garimella K.V., Maguire J.R., Hartl C., et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 2011, 43(5):491-498.
8. Dorschner M.O., Amendola L.M., Turner E.H., Robertson P.D., Shirts B.H., Gallego C.J., et al. Actionable, pathogenic incidental findings in 1000 participants' exomes. Am. J. Hum. Genet. 2013, 93(4):631-640.
9. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1998, 62(3):676-689.
10. Green R.C., Berg J.S., Berry G.T., Biesecker L.G., Dimmock D.P., Evans J.P., et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet. Med. 2012, 14(4):405-410.
11. Green R.C., Berg J.S., Grody W.W., Kalia S.S., Korf B.R., Martin C.L., et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013, 15(7):565-574.
12. Grossniklaus D. Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing. Test category: pharmacogenomic (treatment). PLoS Curr. 2010, 2.
13. Hegde M., Bale S., Bayrak-Toydemir P., Gibson J., Jeng L.J., Joseph L., et al. Reporting incidental findings in genomic scale clinical sequencing - a clinical laboratory perspective: a report of the Association for Molecular Pathology. J. Mol. Diagn. 2015, 17(2):107-117.
14. Jang M.A., Lee S.H., Kim N., Ki C.S. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Genet. Med. 2015, 17(12):1007-1011.
15. Jurgens J., Ling H., Hetrick K., Pugh E., Schiettecatte F., Doheny K., et al. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics. Genet. Med. 2015, 17(10):782-788.
16. Kleiderman E., Knoppers B.M., Fernandez C.V., Boycott K.M., Ouellette G., Wong-Rieger D., et al. Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases. J. Med. Ethics 2014, 40(10):691-696.
17. Knoppers B.M., Deschenes M., Zawati M.H., Tasse A.M. Population studies: return of research results and incidental findings policy statement. Eur. J. Hum. Genet. 2013, 21(3):245-247.
18. Krier J.B., Green R.C. Management of incidental findings in clinical genomic sequencing. Curr. Protoc. Hum. Genet. 2013, (Chapter 9: Unit9 23).
19. Krier J.B., Green R.C. Management of Incidental Findings in Clinical Genomic Sequencing. Curr. Protoc. Hum. Genet. 2015, 87. (9 23 1-9 16).
20. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
21. Lawrence L., Sincan M., Markello T., Adams D.R., Gill F., Godfrey R., et al. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet. Med. 2014, 16(10):741-750.
22. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25(14):1754-1760.
23. Loman N., Johannsson O., Kristoffersson U., Olsson H., Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J. Natl. Cancer Inst. 2001, 93(16):1215-1223.
24. Lum Y.W., Brooke B.S., Black J.H. Contemporary management of vascular Ehlers-Danlos syndrome. Curr. Opin. Cardiol. 2011, 26(6):494-501.
25. Manolio T.A., Chisholm R.L., Ozenberger B., Roden D.M., Williams M.S., Wilson R., et al. Implementing genomic medicine in the clinic: the future is here. Genet. Med. 2013, 15(4):258-267.
26. Manolio T.A., Abramowicz M., Al-Mulla F., Anderson W., Balling R., Berger A.C., et al. Global implementation of genomic medicine: we are not alone. Sci. Transl. Med. 2015, 7(290):290ps13.
27. Mayer A.N., Dimmock D.P., Arca M.J., Bick D.P., Verbsky J.W., Worthey E.A., et al. A timely arrival for genomic medicine. Genet. Med. 2011, 13(3):195-196.
28. McLaughlin H.M., Ceyhan-Birsoy O., Christensen K.D., Kohane I.S., Krier J., Lane W.J., et al. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med. Genet. 2014, 15:134.
29. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31(13):3812-3814.
30. NHGRI The Human Genome Project Completion: Frequently Asked Questions (Accessed 13 October, 2015). https://www.genome.gov/11006943.
31. Priori S.G., Wilde A.A., Horie M., Cho Y., Behr E.R., Berul C., et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013, 10(12):1932-1963.
32. Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17(5):405-423.
33. Roche M.I., Berg J.S. Incidental findings with genomic testing: implications for genetic counseling practice. Curr. Genet. Med. Rep. 2015, 3(4):166-176.
34. Schwarz J.M., Cooper D.N., Schuelke M., Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 2014, 11(4):361-362.
35. Taylor J.C., Martin H.C., Lise S., Broxholme J., Cazier J.B., Rimmer A., et al. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat. Genet. 2015, 47(7):717-726.
36. van El C.G., Cornel M.C., Borry P., Hastings R.J., Fellmann F., Hodgson S.V., et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 2013, 21(Suppl. 1):S1-S5.
37. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 2001, 291(5507):1304-1351.
38. Warner E., Plewes D.B., Hill K.A., Causer P.A., Zubovits J.T., Jong R.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J. Am. Med. Assoc. 2004, 292(11):1317-1325.
39. Wolf S.M., Crock B.N., Van Ness B., Lawrenz F., Kahn J.P., Beskow L.M., et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet. Med. 2012, 14(4):361-384.
40. Wong L.P., Ong R.T., Poh W.T., Liu X., Chen P., Li R., et al. Deep whole-genome sequencing of 100 Southeast Asian Malays. Am. J. Hum. Genet. 2013, 92(1):52-66.
41. Wong L.P., Lai J.K., Saw W.Y., Ong R.T., Cheng A.Y., Pillai N.E., et al. Insights into the genetic structure and diversity of 38 South Asian Indians from deep whole-genome sequencing. PLoS Genet. 2014, 10(5):e1004377.
42. Yu J.H., Crouch J., Jamal S.M., Bamshad M.J., Tabor H.K. Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing. Am. J. Med. Genet. A 2014, 164A(9):2153-2160.
43. Yu J.H., Harrell T.M., Jamal S.M., Tabor H.K., Bamshad M.J. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am. J. Hum. Genet. 2014, 95(1):77-84.